Completed OBSERVATIONAL NCT04138420

Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab

Study of Retinal and Vascular Features by Optical Coherence Tomography and Optical Coherence Tomography Angiography After Intravitreal Injections of Bevacizumab in Exudative Age-related Macular Degeneration

Sponsor: Federico II University

Conditions Exudative Age-related Macular Degeneration

Interventions Bevacizumab Injection

Updated 4 times since 2019 Last updated: Oct 22, 2019 Started: Jan 25, 2017 Primary completion: Oct 25, 2017 Completion: Oct 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Exudative Age-related Macular Degeneration, this trial is completed. The trial is conducted by Federico II University and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Nov 2019 — Jan 2021 [monthly]

Completed

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federico II University

Data source: Federico II University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Naples, Italy